See more : Software Service, Inc. (3733.T) Income Statement Analysis – Financial Results
Complete financial analysis of MediPal Holdings Corporation (MEPDF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MediPal Holdings Corporation, a leading company in the Medical – Distribution industry within the Healthcare sector.
- KBC Group NV (KBCSY) Income Statement Analysis – Financial Results
- ValOre Metals Corp. (VO.V) Income Statement Analysis – Financial Results
- Notable Labs, Ltd. (NTBL) Income Statement Analysis – Financial Results
- Daiwa Industries Ltd. (DAWIF) Income Statement Analysis – Financial Results
- Vivanta Industries Limited (VIVANTA.BO) Income Statement Analysis – Financial Results
MediPal Holdings Corporation (MEPDF)
About MediPal Holdings Corporation
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,558.73B | 3,360.01B | 3,290.92B | 3,211.17B | 3,253.12B | 3,181.94B | 3,146.34B | 3,064.04B | 3,028.24B | 2,872.91B | 2,947.74B | 2,810.91B | 2,750.22B | 2,662.89B | 2,545.99B | 2,463.81B | 2,255.05B | 2,166.85B | 1,921.71B | 1,665.90B |
| Cost of Revenue | 3,312.08B | 3,135.70B | 3,073.48B | 2,996.91B | 3,016.38B | 2,949.43B | 2,918.24B | 2,845.02B | 2,810.74B | 2,671.18B | 2,738.38B | 2,608.77B | 2,557.65B | 2,474.74B | 2,354.89B | 2,276.57B | 2,063.39B | 1,978.61B | 1,760.11B | 1,528.10B |
| Gross Profit | 246.66B | 224.31B | 217.45B | 214.26B | 236.74B | 232.50B | 228.10B | 219.02B | 217.50B | 201.74B | 209.36B | 202.14B | 192.57B | 188.15B | 191.09B | 187.24B | 191.65B | 188.24B | 161.60B | 137.81B |
| Gross Profit Ratio | 6.93% | 6.68% | 6.61% | 6.67% | 7.28% | 7.31% | 7.25% | 7.15% | 7.18% | 7.02% | 7.10% | 7.19% | 7.00% | 7.07% | 7.51% | 7.60% | 8.50% | 8.69% | 8.41% | 8.27% |
| Research & Development | 991.00M | 103.00M | 108.00M | 106.00M | 118.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 165.20B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.90B | 7.95B | 8.35B | 7.46B | 8.21B | 13.02B | 9.55B | 6.87B |
| Selling & Marketing | 20.47B | 18.81B | 18.62B | 18.67B | 18.93B | 17.35B | 16.15B | 16.02B | 14.54B | 13.68B | 13.86B | 13.98B | 14.57B | 14.69B | 14.65B | 14.73B | 13.42B | 0.00 | 0.00 | 0.00 |
| SG&A | 185.68B | 18.81B | 18.62B | 18.67B | 18.93B | 17.35B | 16.15B | 16.02B | 14.54B | 13.68B | 13.86B | 13.98B | 22.47B | 22.64B | 23.00B | 22.19B | 21.63B | 13.02B | 9.55B | 6.87B |
| Other Expenses | 178.85B | 9.96B | 10.24B | 9.16B | 9.24B | 9.85B | 9.32B | 9.13B | 9.19B | 8.65B | 8.97B | 8.51B | 10.46B | 9.58B | 9.02B | 16.09B | 14.89B | 14.33B | 13.22B | 13.83B |
| Operating Expenses | 199.33B | 175.33B | 171.82B | 175.68B | 183.63B | 182.67B | 183.84B | 179.36B | 175.21B | 168.94B | 174.69B | 173.62B | 130.42B | 132.86B | 131.99B | 132.22B | 123.37B | 120.84B | 106.13B | 95.99B |
| Cost & Expenses | 3,511.40B | 3,311.03B | 3,245.29B | 3,172.59B | 3,200.01B | 3,132.10B | 3,102.08B | 3,024.39B | 2,985.95B | 2,840.11B | 2,913.07B | 2,782.39B | 2,688.07B | 2,607.60B | 2,486.89B | 2,408.79B | 2,186.76B | 2,099.45B | 1,866.24B | 1,624.09B |
| Interest Income | 29.00M | 101.00M | 177.00M | 178.00M | 194.00M | 199.00M | 125.00M | 64.00M | 138.00M | 158.00M | 142.00M | 135.00M | 130.00M | 141.00M | 189.00M | 302.00M | 350.00M | 248.00M | 249.00M | 272.00M |
| Interest Expense | 8.00M | 34.00M | 16.00M | 50.00M | 137.00M | 180.00M | 237.00M | 303.00M | 345.00M | 361.00M | 426.00M | 513.00M | 602.00M | 695.00M | 842.00M | 841.00M | 552.00M | 417.00M | 353.00M | 1.43B |
| Depreciation & Amortization | 17.98B | 14.65B | 14.34B | 14.79B | 14.69B | 13.93B | 15.37B | 13.79B | 12.46B | 12.33B | 13.15B | 12.62B | 12.72B | 14.02B | 14.33B | 7.28B | 5.90B | 6.21B | 3.56B | 997.00M |
| EBITDA | 65.31B | 63.62B | 59.96B | 53.37B | 67.80B | 63.40B | 59.64B | 53.05B | 54.58B | 45.12B | 47.81B | 53.03B | 39.13B | 22.38B | 23.86B | 29.70B | 49.59B | 40.97B | 33.90B | 20.54B |
| EBITDA Ratio | 1.84% | 2.38% | 2.32% | 2.11% | 2.55% | 2.46% | 2.37% | 2.21% | 2.25% | 1.99% | 2.16% | 1.73% | 3.12% | 2.98% | 3.25% | 3.44% | 4.19% | 4.31% | 4.03% | 3.79% |
| Operating Income | 47.33B | 48.97B | 45.62B | 38.58B | 53.11B | 49.83B | 44.26B | 39.65B | 42.28B | 32.80B | 34.66B | 28.52B | 20.89B | 13.55B | 18.43B | 13.46B | 27.95B | 27.78B | 20.61B | 10.99B |
| Operating Income Ratio | 1.33% | 1.46% | 1.39% | 1.20% | 1.63% | 1.57% | 1.41% | 1.29% | 1.40% | 1.14% | 1.18% | 1.01% | 0.76% | 0.51% | 0.72% | 0.55% | 1.24% | 1.28% | 1.07% | 0.66% |
| Total Other Income/Expenses | 27.41B | 21.09B | 11.66B | 10.66B | 22.43B | 13.63B | 19.21B | 12.80B | 12.52B | 12.13B | 13.84B | 11.38B | 4.91B | -4.91B | -9.75B | 8.13B | 15.19B | 496.00M | 9.50B | 8.32B |
| Income Before Tax | 74.74B | 70.06B | 57.28B | 49.24B | 75.54B | 63.46B | 63.47B | 52.45B | 54.81B | 44.92B | 48.50B | 39.90B | 25.80B | 8.64B | 8.69B | 21.58B | 43.14B | 34.34B | 30.11B | 19.30B |
| Income Before Tax Ratio | 2.10% | 2.09% | 1.74% | 1.53% | 2.32% | 1.99% | 2.02% | 1.71% | 1.81% | 1.56% | 1.65% | 1.42% | 0.94% | 0.32% | 0.34% | 0.88% | 1.91% | 1.58% | 1.57% | 1.16% |
| Income Tax Expense | 22.97B | 21.74B | 18.09B | 15.62B | 24.31B | 18.04B | 19.93B | 16.12B | 17.88B | 15.82B | 18.40B | 17.26B | 11.38B | 5.43B | 6.73B | 9.08B | 15.35B | 15.23B | 9.27B | 10.50B |
| Net Income | 41.47B | 38.81B | 29.42B | 23.93B | 37.97B | 34.36B | 34.78B | 29.01B | 30.77B | 23.69B | 25.49B | 18.66B | 11.65B | 1.70B | 1.96B | 12.51B | 27.79B | 19.11B | 20.84B | 8.73B |
| Net Income Ratio | 1.17% | 1.15% | 0.89% | 0.75% | 1.17% | 1.08% | 1.11% | 0.95% | 1.02% | 0.82% | 0.86% | 0.66% | 0.42% | 0.06% | 0.08% | 0.51% | 1.23% | 0.88% | 1.08% | 0.52% |
| EPS | 195.83 | 184.82 | 140.13 | 113.95 | 175.80 | 145.15 | 154.13 | 128.12 | 135.89 | 104.73 | 112.77 | 82.24 | 49.60 | 7.27 | 8.31 | 52.30 | 119.20 | 82.86 | 97.64 | 45.90 |
| EPS Diluted | 195.83 | 179.12 | 131.41 | 106.80 | 165.33 | 145.15 | 149.91 | 128.12 | 135.89 | 104.73 | 112.77 | 82.24 | 49.60 | 7.27 | 8.31 | 52.22 | 118.53 | 82.29 | 94.22 | 43.52 |
| Weighted Avg Shares Out | 211.78M | 209.96M | 209.96M | 209.96M | 215.98M | 236.71M | 225.66M | 226.44M | 226.44M | 226.19M | 226.00M | 226.85M | 234.91M | 234.56M | 235.73M | 239.19M | 233.18M | 230.58M | 209.01M | 185.08M |
| Weighted Avg Shares Out (Dil) | 211.78M | 216.35M | 223.12M | 223.06M | 229.02M | 236.71M | 232.01M | 226.44M | 226.44M | 226.19M | 226.00M | 226.85M | 234.91M | 234.56M | 235.73M | 239.56M | 234.49M | 232.17M | 221.21M | 200.57M |
Source: https://incomestatements.info
Category: Stock Reports